AI assistant
Sending…
ADMA BIOLOGICS, INC. — Director's Dealing 2012
Feb 16, 2012
31261_dirs_2012-02-15_60f12639-f61f-40f3-835e-d159f777ba73.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: R&R ACQUISITION VI, INC (NONE)
CIK: 0001368514
Period of Report: 2012-02-13
Reporting Person: GOLDSTEIN DOV A MD (Director)
More from ADMA BIOLOGICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 2
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 3